Cargando…
Efficacy of Carvedilol in Patients with Dilated Cardiomyopathy due to Beta-thalassemia major; a Double-blind Randomized Controlled Trial
OBJECTIVE: Dilated cardiomyopathy is the end result of chronic iron overload in patients with beta thalassemia major. The objective of the present study was to evaluate the safety and efficacy of Carvedilol in patients with beta thalassemia major and dilated cardiomyopathy. METHODS: During a six-mon...
Autores principales: | Ajami, Gholam-Hossein, Amoozgar, Hamid, Borzouee, Mohammad, Karimi, Mehran, Piravian, Farah, Ashrafi, Afsaneh, Kheirandish, Zahra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Tehran University of Medical Sciences
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3446036/ https://www.ncbi.nlm.nih.gov/pubmed/23056717 |
Ejemplares similares
-
Serum lipid profiles in patients with beta-thalassemia major and intermedia in southern Iran
por: Haghpanah, Sezaneh, et al.
Publicado: (2010) -
Serum Ferritin Levels Correlation With Heart and Liver MRI and LIC in Patients With Transfusion-Dependent Thalassemia
por: Majd, Zahra, et al.
Publicado: (2015) -
The Role of Carvedilol in the Treatment of Dilated and Anthracyclines-Induced Cardiomyopathy
por: Watanabe, Kenichi, et al.
Publicado: (2011) -
Persistent Truncus Arteriosus With Intact Ventricular Septum: Clinical, Hemodynamic and Short-term Surgical Outcome
por: Ajami, Gholamhossein, et al.
Publicado: (2015) -
Prevalence of Celiac Disease in Children with Idiopathic Dilated Cardiomyopathy
por: Zahmatkeshan, Mozhgan, et al.
Publicado: (2014)